Telo Genomics (TSXV:TELO) announced the appointment of John Farlinger to its board of directors (BOD) and will serve as chair of the company’s audit committee.
With more than 30 years of experience in telecom, operations, technology, and finance, Mr. Farlinger is a veteran venture and private equity backed executive and entrepreneur. He is currently serving as executive chairman and CEO of Assure Neuromonitoring, and is a chartered professional accountant.
In a statement, Guido Baechler, executive chairman of Telo, said, “We are thrilled to welcome John to our board, and we look forward to working together. His experience in strategic leadership and financing small cap growth companies is an excellent fit for the current stage of development of Telo Genomics.”
